These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32991515)

  • 1. One Year Outcomes From a Prospective Multicenter Investigation Device Trial of a Novel Conformal Mesh Interbody Fusion Device.
    Driver J; Huang KT; Krag M; Bydon M; Nunley P; Lavoie S; Lu Y; Stone M; Chi JH
    Spine (Phila Pa 1976); 2021 Jan; 46(2):E126-E132. PubMed ID: 32991515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-Year Outcomes From a Prospective Multicenter Investigation Device Trial of a Novel Conformal Mesh Interbody Fusion Device.
    Chi JH; Nunley PD; Huang KT; Krag MH; Bydon M; Lavoie S; Lu Y; Driver J; Stone MB
    Int J Spine Surg; 2021 Dec; 15(6):1103-1114. PubMed ID: 35086867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term durability of minimal invasive posterior transforaminal lumbar interbody fusion: a clinical and radiographic follow-up.
    Rouben D; Casnellie M; Ferguson M
    J Spinal Disord Tech; 2011 Jul; 24(5):288-96. PubMed ID: 20975594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lumbar disc arthroplasty versus anterior lumbar interbody fusion: 5-year outcomes for patients in the Maverick disc investigational device exemption study.
    Gornet MF; Burkus JK; Dryer RF; Peloza JH; Schranck FW; Copay AG
    J Neurosurg Spine; 2019 May; 31(3):347-356. PubMed ID: 31100723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do measures of surgical effectiveness at 1 year after lumbar spine surgery accurately predict 2-year outcomes?
    Adogwa O; Elsamadicy AA; Han JL; Cheng J; Karikari I; Bagley CA
    J Neurosurg Spine; 2016 Dec; 25(6):689-696. PubMed ID: 26722957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Preliminary clinical outcomes between percutaneous endoscopic and minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative diseases in a tertiary hospital: Is percutaneous endoscopic procedure superior to MIS-TLIF? A prospective cohort study.
    Ao S; Zheng W; Wu J; Tang Y; Zhang C; Zhou Y; Li C
    Int J Surg; 2020 Apr; 76():136-143. PubMed ID: 32165279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: five-year follow-up.
    Guyer RD; McAfee PC; Banco RJ; Bitan FD; Cappuccino A; Geisler FH; Hochschuler SH; Holt RT; Jenis LG; Majd ME; Regan JJ; Tromanhauser SG; Wong DC; Blumenthal SL
    Spine J; 2009 May; 9(5):374-86. PubMed ID: 18805066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, multi-institutional comparative effectiveness study of lumbar spine surgery in morbidly obese patients: does minimally invasive transforaminal lumbar interbody fusion result in superior outcomes?
    Adogwa O; Carr K; Thompson P; Hoang K; Darlington T; Perez E; Fatemi P; Gottfried O; Cheng J; Isaacs RE
    World Neurosurg; 2015 May; 83(5):860-6. PubMed ID: 25535070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of radiographic and clinical outcomes of an articulating expandable interbody cage in minimally invasive transforaminal lumbar interbody fusion for spondylolisthesis.
    Massie LW; Zakaria HM; Schultz LR; Basheer A; Buraimoh MA; Chang V
    Neurosurg Focus; 2018 Jan; 44(1):E8. PubMed ID: 29290133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, randomized, multicenter Food and Drug Administration investigational device exemptions study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: part I: evaluation of clinical outcomes.
    Blumenthal S; McAfee PC; Guyer RD; Hochschuler SH; Geisler FH; Holt RT; Garcia R; Regan JJ; Ohnmeiss DD
    Spine (Phila Pa 1976); 2005 Jul; 30(14):1565-75; discussion E387-91. PubMed ID: 16025024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisions for screw malposition and clinical outcomes after robot-guided lumbar fusion for spondylolisthesis.
    Schröder ML; Staartjes VE
    Neurosurg Focus; 2017 May; 42(5):E12. PubMed ID: 28463610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and radiographic outcomes of bilateral decompression via a unilateral approach with transforaminal lumbar interbody fusion for degenerative lumbar spondylolisthesis with stenosis.
    Cheng X; Zhang K; Sun X; Zhao C; Li H; Ni B; Zhao J
    Spine J; 2017 Aug; 17(8):1127-1133. PubMed ID: 28416439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lumbar disc arthroplasty with Maverick disc versus stand-alone interbody fusion: a prospective, randomized, controlled, multicenter investigational device exemption trial.
    Gornet MF; Burkus JK; Dryer RF; Peloza JH
    Spine (Phila Pa 1976); 2011 Dec; 36(25):E1600-11. PubMed ID: 21415812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of local steroid application in a minimally invasive transforaminal lumbar interbody fusion: results of a prospective, randomized, single-blind trial.
    Haws BE; Khechen B; Patel DV; Bawa MS; Ahn J; Bohl DD; Mayo BC; Massel DH; Guntin JA; Cardinal KL; Singh K
    J Neurosurg Spine; 2018 Nov; 30(2):222-227. PubMed ID: 30497132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 'Lumbar Fusion Outcome Score' (LUFOS): a new practical and surgically oriented grading system for preoperative prediction of surgical outcomes after lumbar spinal fusion in patients with degenerative disc disease and refractory chronic axial low back pain.
    Mattei TA; Rehman AA; Teles AR; Aldag JC; Dinh DH; McCall TD
    Neurosurg Rev; 2017 Jan; 40(1):67-81. PubMed ID: 27289367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of multilevel lateral interbody fusion of the thoracolumbar coronal curve apex in adult deformity surgery in combination with open posterior instrumentation and L5-S1 interbody fusion: a case-matched evaluation of 32 patients.
    Theologis AA; Mundis GM; Nguyen S; Okonkwo DO; Mummaneni PV; Smith JS; Shaffrey CI; Fessler R; Bess S; Schwab F; Diebo BG; Burton D; Hart R; Deviren V; Ames C;
    J Neurosurg Spine; 2017 Feb; 26(2):208-219. PubMed ID: 27767682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction based on preoperative opioid use of clinical outcomes after transforaminal lumbar interbody fusions.
    Villavicencio AT; Nelson EL; Kantha V; Burneikiene S
    J Neurosurg Spine; 2017 Feb; 26(2):144-149. PubMed ID: 27689425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Inextensible Endoscopic Tube Versus Traditional Extensible Retractor System in Single-Level Minimally Invasive Transforaminal Lumbar Interbody Fusion: A Prospective Observation Study.
    Wu J; Zhang C; Lu K; Li C; Zhou Y
    Pain Physician; 2019 Nov; 22(6):E587-E599. PubMed ID: 31775412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [COMPARISON OF EFFECTIVENESS BETWEEN PARA-MEDIAN INCISION MINIMALLY INVASIVE AND OPEN TRANSFORAMINAL LUMBAR INTERBODY FUSION FOR SINGLE SEGMENTAL LUMBAR DEGENERATIVE DISEASE].
    Qi Q; Xiao Q; Deng L; Li C; Dong X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2015 Oct; 29(10):1253-8. PubMed ID: 26749734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally invasive transforaminal lumbar interbody fusion with expandable versus static interbody devices: radiographic assessment of sagittal segmental and pelvic parameters.
    Hawasli AH; Khalifeh JM; Chatrath A; Yarbrough CK; Ray WZ
    Neurosurg Focus; 2017 Aug; 43(2):E10. PubMed ID: 28760032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.